| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $138.1M | +36.4% |
| R&D Expense | $83.4M | +7.3% |
| SG&A Expense | $29.7M | -1.0% |
| Operating Income | $25.0M | +485.5% |
| Pre-tax Income | $32.1M | +865.8% |
| Income Tax | $224K | -94.2% |
| Net Income | $31.9M | +5700.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.1M | +121.6% |
| Accounts Receivable | $3.1M | -9.6% |
| Current Assets | $107.3M | -41.3% |
| Total Assets | $120.5M | -40.3% |
| Current Liabilities | $85.8M | -45.0% |
| Total Liabilities | $121.0M | -51.5% |
| Stockholders' Equity | -$456K | +99.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.2M | -53.9% |
| Capital Expenditures | $310K | -63.1% |
| Investing Cash Flow | $99.7M | +166.2% |
| Financing Cash Flow | $7.5M | -75.1% |
| Free Cash Flow | -$86.5M | -52.2% |